07:13 IST
BSE
Merger & Restructuring
Lupin Merger & Restructuring Worth ₹15.36 Cr
Lupin Inc. licensed two oncology programs to Kaveri Therapeutics in exchange for an 82.2% stake, valued at ₹15.36 Crore.
- Value
- ₹15.36 Cr